These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


129 related items for PubMed ID: 8941597

  • 1. Crescentic glomerulonephritis associated with p-ANCA positivity in fludarabine-treated chronic lymphocytic leukaemia.
    Tisler A, Pierratos A, Lipton JH.
    Nephrol Dial Transplant; 1996 Nov; 11(11):2306-8. PubMed ID: 8941597
    [No Abstract] [Full Text] [Related]

  • 2. Crescentic glomerulonephritis with antineutrophil cytoplasmic antibodies associated with chronic lymphocytic leukaemia.
    Dussol B, Brunet P, Vacher-Coponat H, Bouabdallah R, Chetaille P, Berland Y.
    Nephrol Dial Transplant; 1997 Apr; 12(4):785-6. PubMed ID: 9141013
    [No Abstract] [Full Text] [Related]

  • 3. Fludarabine therapy in chronic lymphocytic leukemia-associated severe nephrotic syndrome.
    Abdel-Raheem MM, Jamil MG, Potti A, Gross GG.
    Haematologica; 2000 Nov; 85(11):1224-5. PubMed ID: 11064479
    [No Abstract] [Full Text] [Related]

  • 4. Rare association of chronic lymphocytic leukemia/small lymphocytic lymphoma, ANCAs, and pauci-immune crescentic glomerulonephritis.
    Henriksen KJ, Hong RB, Sobrero MI, Chang A.
    Am J Kidney Dis; 2011 Jan; 57(1):170-4. PubMed ID: 20974512
    [Abstract] [Full Text] [Related]

  • 5. Irreversible renal failure in a patient with chronic lymphocytic leukemia treated with fludarabine.
    Timuragaoglu A, Karadogan I, Undar L.
    Ann Hematol; 1999 Feb; 78(2):109-10. PubMed ID: 10089031
    [No Abstract] [Full Text] [Related]

  • 6. Severe autoimmune hemolytic anemia in two patients treated with fludarabine for chronic lymphocytic leukemia.
    Bastion Y, Coiffier B, Dumontet C, Espinouse D, Bryon PA.
    Ann Oncol; 1992 Feb; 3(2):171-2. PubMed ID: 1606091
    [No Abstract] [Full Text] [Related]

  • 7. A phase II trial of fludarabine in patients with previously treated chronic lymphocytic leukaemia.
    Hocepied AM, Falkson CI, Falkson G.
    S Afr Med J; 1996 May; 86(5):549-50. PubMed ID: 8711555
    [Abstract] [Full Text] [Related]

  • 8. Opportunistic infections in patients with chronic lymphocytic leukemia following treatment with fludarabine.
    Sanders C, Perez EA, Lawrence HJ.
    Am J Hematol; 1992 Apr; 39(4):314-5. PubMed ID: 1553963
    [No Abstract] [Full Text] [Related]

  • 9. Cytopenia and fludarabine.
    Jaccard A, Oksenhendler E, Clauvel JP.
    Lancet; 1993 Oct 23; 342(8878):1049-50. PubMed ID: 8105278
    [No Abstract] [Full Text] [Related]

  • 10. [Progressive multifocal leukoencephalopathy in a patient with chronic lymphatic leukemia treated with fludarabine].
    Mata MI, Gardella S, del Mar Castellanos M, Ortiz MR.
    Med Clin (Barc); 2000 Nov 04; 115(15):598-9. PubMed ID: 11141397
    [No Abstract] [Full Text] [Related]

  • 11. Renal failure in a patient with chronic lymphocytic leukaemia treated with fludarabine.
    Macheta MP, Parapia LA, Gouldesbrough DR.
    J Clin Pathol; 1995 Feb 04; 48(2):181-2. PubMed ID: 7745121
    [Abstract] [Full Text] [Related]

  • 12. Listerial brain abscess in a patient with chronic lymphocytic leukemia treated with fludarabine.
    Cleveland KO, Gelfand MS.
    Clin Infect Dis; 1993 Oct 04; 17(4):816-7. PubMed ID: 8268374
    [No Abstract] [Full Text] [Related]

  • 13. Fludarabine approved for use in chronic lymphocytic leukemia.
    Oncology (Williston Park); 1991 Jun 04; 5(6):20. PubMed ID: 1831638
    [No Abstract] [Full Text] [Related]

  • 14. Fludarabine for chronic lymphocytic leukemia.
    Erman M, Celik I, Tekuzman G.
    N Engl J Med; 2001 Apr 12; 344(15):1166; author reply 1167-8. PubMed ID: 11302142
    [No Abstract] [Full Text] [Related]

  • 15. Transfusion-associated graft-versus-host disease in fludarabine-treated B-chronic lymphocytic leukaemia.
    Maung ZT, Wood AC, Jackson GH, Turner GE, Appleton AL, Hamilton PJ.
    Br J Haematol; 1994 Nov 12; 88(3):649-52. PubMed ID: 7819085
    [Abstract] [Full Text] [Related]

  • 16. Cryptococcus lung infection complicating fludarabine treatment in a chronic lymphocytic leukemia patient.
    Benetatos L, Hatzimichael E, Vassou A, Bourantas KL.
    Leuk Res; 2007 Jan 12; 31(1):119-20. PubMed ID: 16620969
    [No Abstract] [Full Text] [Related]

  • 17. Autoimmune thrombocytopenia due to chronic lymphocytic leukemia treated with fludarabine.
    Wells T, Kovacs MJ.
    Ann Pharmacother; 2003 May 12; 37(5):671-4. PubMed ID: 12708944
    [Abstract] [Full Text] [Related]

  • 18. What choices are available for treatment of the patient with chronic lymphocytic leukemia who is fludarabine-refractory?
    Byrd JC, Rai KR.
    Semin Oncol; 2000 Aug 12; 27(4):xii-xv; discussion xv-xvi. PubMed ID: 10950363
    [No Abstract] [Full Text] [Related]

  • 19. Fludarabine-related autoimmune haemolytic anaemia in patients with chronic lymphocytic leukaemia.
    Myint H, Copplestone JA, Orchard J, Craig V, Curtis D, Prentice AG, Hamon MD, Oscier DG, Hamblin TJ.
    Br J Haematol; 1995 Oct 12; 91(2):341-4. PubMed ID: 8547072
    [Abstract] [Full Text] [Related]

  • 20. [Successful treatment with fludarabine of chronic lymphocytic leukemia associated with nephrotic syndrome].
    Takei K, Horikoshi A, Hosokawa Y, Sawada S, Horie T.
    Rinsho Ketsueki; 2002 Nov 12; 43(11):993-7. PubMed ID: 12508485
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.